Safety Finding Based on Blinded MRI Brain Data at Week 40ARIA is a Known Risk Factor for Anti-Amyloid Antibody DrugsMRI Data Presented at the 16th CTAD.
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher after the company announced MRI data suggested simufilam is not associated with amyloid-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips An investigation into one of Cassava Sciences' advisors is pushing shares down. Here's why…
CUNY’s report makes no findings of data manipulation.The “egregious misconduct” cited in the report relates to internal record-keeping failures at CUNY.CUNY’s report finds that internal.